New subsidiary of The Medical Affairs Co. hopes to fill gaps in CSO offerings
Pharmaceutical Commerce - March/April 2016
Connectivity with patients drives pharma growth
Even though recombinant-DNA biologics are displacing traditional blood-sourced therapeutics, maintaining stable supplies is still a problem
Future tech, serialization and South America
The anatomy of an optimized sampling supply chain
Company is now a certified supplier for Walgreens
Pharmaceutical Commerce's annual Cold Chain Sourcebook projects 52% growth between 2014 and 2020
Flexi-Cap Protect prevents breakage at both the tops and bottoms of vials
Discerning how and where products are discounted is an expensive headache for manufacturers
Dramatic changes are seeping into how pharma companies manage diverse datasets
Better local resources around the world and more sophisticated technology are changing the dynamics of logistics services
A new, market-driven model of drug development and commercialization is appearing*
Looking at 'cost' and 'value' under different evaluation processes
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Novo Nordisk’s Bloomington Plant Receives FDA OAI Designation Following Contamination and Compliance Issues
2
Pharma Pulse: Kaiser Permanente Strike Escalates, Takeda Partners with Nabla Bio, and FDA Flags Novo Nordisk Bloomington Site
3
United States Delays Tariffs on Singapore’s Pharma Exports Amid Ongoing Trade Negotiations
4
How Healthcare Organizations Can Balance Federal and State AI Regulations
5
